Journal of Global Antimicrobial Resistance · 2020 · 22 citations · 9 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDiagnostic MicrobiologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance GeneticsAntimicrobial Resistance GenomicsBacterial InfectionsCarbapenem ResistanceAmpc Beta-lactamasesAntimicrobial Resistance Gene DetectionCarbapenem AntibioticsCarbapenem Resistance MechanismsCarbapenemase EnzymesEscherichia ColiKlebsiella Pneumoniae CarbapenemaseResistance In Clinical Isolates
The aim of this study was to investigate the molecular mechanisms of imipenem resistance in Enterobacteriaceae and to assess the antimicrobial activities of ceftazidime/avibactam (CAZ/AVI) and aztreonam/avibactam (ATM/AVI) against imipenem-resistant clinical isolates in a tertiary hospital in China. A total of 91 imipenem-resistant Enterobacteriaceae were collected and genes encoding carbapenemases, ESBLs, AmpC β-lactamases and porins were detected using PCR. MICs and susceptibility were determined using in-house-prepared broth microdilution panels and were interpreted according to CLSI breakpoints. Imipenem-resistant isolates comprising 54 Klebsiella pneumoniae, 18 Escherichia coli, 8 Enterobacter cloacae, 6 Serratia marcescens, 3 Klebsiella oxytoca and 2 Klebsiella aerogenes were collected independently. Five different carbapenemase genes were identified, namely blaKPC-2 (n = 60), blaNDM-5 (n = 14), blaNDM-1 (n = 11), blaKPC-3 (n = 4) and blaIMP-4 (n = 1). Among the 91 carbapenem-resistant Enterobacteriaceae (CRE), 85 isolates harboured at least one ESBL and/or AmpC gene, including 5 strains without carbapenemase-encoding genes. Moreover, 31 K. pneumoniae carried ompK35 and/or ompK36 mutations. MLST results showed that the K. pneumoniae belonged to 12 different STs, with ST11 being predominant (29/54; 53.7%). Overall, 17.6%, 25.3%, 41.8%, 65.9% and 100% of the CRE strains were susceptible to amikacin, trimethoprim/sulfamethoxazole, tetracycline, CAZ/AVI and ATM/AVI, respectively. This study revealed that CRE isolates differ significantly in their species, STs, porins and carbapenemase genes in a single Chinese hospital. ATM/AVI exhibited potent activity against CRE isolates, even for the most notorious double-carbapenemase-producers with porin defects, whereas CAZ/AVI was active against all the non-metallo-β-lactamase-producing isolates.
9
Qi Wang, Xiaojuan Wang, Juan Wang et al. · Clinical Infectious Diseases · 2018 · 360 citations · Full text
Emergence of NDM-1-producing Acinetobacter baumannii in China
Yan Chen, Zhihui Zhou, Yan Jiang et al. · Journal of Antimicrobial Chemotherapy · 2011 · 269 citations
Melissa D. Barnes, Marisa Winkler, Magdalena A. Taracila et al. · mBio · 2017 · 126 citations · Full text
Antimicrobial resistance: a threat to global health
Youngmee Jee, Johan E. Carlson, Eric Rafai et al. · The Lancet Infectious Diseases · 2018 · 126 citations
Hélio S. Sader, Mariana Castanheira, Dee Shortridge et al. · Antimicrobial Agents and Chemotherapy · 2017 · 120 citations · Full text